{"protocolSection": {"identificationModule": {"nctId": "NCT02725008", "orgStudyIdInfo": {"id": "714220-1"}, "organization": {"fullName": "New York Presbyterian Brooklyn Methodist Hospital", "class": "OTHER"}, "briefTitle": "Trial of One Versus Two Doses of Dexamethasone for Pediatric Asthma Exacerbation", "officialTitle": "A Randomized Double Blinded Placebo Controlled Trial of One Versus Two Doses of Oral Dexamethasone for the Treatment of Acute Asthma Exacerbation in the Pediatric Emergency Department (ED)", "acronym": "R2D2"}, "statusModule": {"statusVerifiedDate": "2019-02", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2015-11"}, "primaryCompletionDateStruct": {"date": "2017-11", "type": "ACTUAL"}, "completionDateStruct": {"date": "2017-11", "type": "ACTUAL"}, "studyFirstSubmitDate": "2016-03-18", "studyFirstSubmitQcDate": "2016-03-24", "studyFirstPostDateStruct": {"date": "2016-03-31", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2018-11-30", "resultsFirstSubmitQcDate": "2019-02-25", "resultsFirstPostDateStruct": {"date": "2019-02-27", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2019-02-25", "lastUpdatePostDateStruct": {"date": "2019-02-27", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR_INVESTIGATOR", "investigatorFullName": "Geoffrey W Jara-Almonte", "investigatorTitle": "Sub-Investigator", "investigatorAffiliation": "New York Presbyterian Brooklyn Methodist Hospital"}, "leadSponsor": {"name": "Geoffrey W Jara-Almonte", "class": "OTHER"}}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "Comparing one versus two doses of oral dexamethasone for the treatment of asthma in the pediatric emergency department.", "detailedDescription": "A randomized double blinded placebo controlled trial comparing one dose of dexamethasone administered in the Emergency Department with two doses, the first given in the emergency department and the second 24 hours after the index ED visit."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["Asthma", "Pediatric", "Emergency Department", "Dexamethasone", "Steroid"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "QUADRUPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 99, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Control", "type": "ACTIVE_COMPARATOR", "description": "Patients are given one dose of oral dexamethasone 0.6 milligrams per kilogram up to 16 milligrams in the ED and a second dose of 0.6 milligrams per kilogram up to 16 milligrams to take 24 hours after ED visit", "interventionNames": ["Drug: Dexamethasone"]}, {"label": "Investigational", "type": "EXPERIMENTAL", "description": "Patients are given one dose of oral dexamethasone 0.6 milligrams per kilogram up to 16 milligrams in the ED and placebo to be taken 24 hours after ED visit", "interventionNames": ["Drug: Dexamethasone", "Drug: placebo"]}], "interventions": [{"type": "DRUG", "name": "Dexamethasone", "armGroupLabels": ["Control", "Investigational"], "otherNames": ["decadron"]}, {"type": "DRUG", "name": "placebo", "description": "to be given to the experimental group on the day after discharge from the ED in lieu of the second dose of dexamethasone", "armGroupLabels": ["Investigational"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Treatment Failure", "description": "number of patients who experience any of the following outcomes - unplanned hospital admission for asthma symptoms, unplanned ED visit for asthma symptoms, unplanned urgent care visit for asthma symptoms, unplanned primary care physician visit for asthma symptoms, or prescription of a course of steroids", "timeFrame": "5 days"}], "secondaryOutcomes": [{"measure": "Change in Symptom Severity From Day 1 to Day 5", "description": "Severity of asthma symptoms as reported by the Patient Self Assessment Score. Patients assessed severity of asthma symptoms in 4 categories (wheezing, coughing, activity and sleep) once per day during the 5 days between study enrollment and follow-up. Score range is 0 - 12 with 0 being mildest symptoms and 12 being most severe symptoms. Reported as change in score between enrollment (day 1) and follow-up (day 5).", "timeFrame": "5 days"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* History of asthma defined as at least two (2) prior episodes of respiratory illness characterized by wheezing treated with inhaled beta agonists\n\nExclusion Criteria:\n\n* pregnancy\n* severe chronic cardiac, respiratory, neurological or neuromuscular disease\n* complete resolution of symptoms after one treatment of beta agonists\n* severe asthma symptoms as defined by a Pulmonary Index Score of 12 or greater", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Months", "maximumAge": "20 Years", "stdAges": ["CHILD", "ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Christopher Kelly, MD", "affiliation": "New York Presbyterian Brooklyn Methodist Hospital", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "New York Methodist Hospital", "city": "Brooklyn", "state": "New York", "zip": "11215", "country": "United States", "geoPoint": {"lat": 40.6501, "lon": -73.94958}}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "99 participants were enrolled, 2 participants underwent initial enrollment but were not randomized to a group, leaving 97 participants who were assigned to a study group.", "recruitmentDetails": "Pediatric Emergency Department", "groups": [{"id": "FG000", "title": "Control", "description": "Patients are given one dose of oral dexamethasone 0.6 milligrams per kilogram up to 16 milligrams in the ED and a second dose of 0.6 milligrams per kilogram up to 16 milligrams to take 24 hours after ED visit\n\nDexamethasone"}, {"id": "FG001", "title": "Investigational", "description": "Patients are given one dose of oral dexamethasone 0.6 milligrams per kilogram up to 16 milligrams in the ED and placebo to be taken 24 hours after ED visit\n\nDexamethasone\n\nplacebo: to be given to the experimental group on the day after discharge from the ED in lieu of the second dose of dexamethasone"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "46"}, {"groupId": "FG001", "numSubjects": "51"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "37"}, {"groupId": "FG001", "numSubjects": "39"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "9"}, {"groupId": "FG001", "numSubjects": "12"}]}], "dropWithdraws": [{"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "7"}, {"groupId": "FG001", "numSubjects": "9"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "2"}]}, {"type": "Admitted to hospital", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Control", "description": "Patients are given one dose of oral dexamethasone 0.6 milligrams per kilogram up to 16 milligrams in the ED and a second dose of 0.6 milligrams per kilogram up to 16 milligrams to take 24 hours after ED visit\n\nDexamethasone"}, {"id": "BG001", "title": "Investigational", "description": "Patients are given one dose of oral dexamethasone 0.6 milligrams per kilogram up to 16 milligrams in the ED and placebo to be taken 24 hours after ED visit\n\nDexamethasone\n\nplacebo: to be given to the experimental group on the day after discharge from the ED in lieu of the second dose of dexamethasone"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "46"}, {"groupId": "BG001", "value": "51"}, {"groupId": "BG002", "value": "97"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "9.4", "spread": "6.0"}, {"groupId": "BG001", "value": "7", "spread": "5.4"}, {"groupId": "BG002", "value": "8.4", "spread": "5.7"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "12"}, {"groupId": "BG001", "value": "19"}, {"groupId": "BG002", "value": "31"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "34"}, {"groupId": "BG001", "value": "32"}, {"groupId": "BG002", "value": "66"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "24"}, {"groupId": "BG001", "value": "31"}, {"groupId": "BG002", "value": "55"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "19"}, {"groupId": "BG001", "value": "15"}, {"groupId": "BG002", "value": "34"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "2"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "3"}, {"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "6"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "46"}, {"groupId": "BG001", "value": "51"}, {"groupId": "BG002", "value": "97"}]}]}]}, {"title": "PIS Score", "description": "Pulmonary Index Score - a clinical tool to assess severity of asthma exacerbation in children. Includes respiratory rate, amount of wheezing, I:E ratio, degree of accessory muscle use and oxygen saturation. Each subsection may be scored 0-3. Total score is arrived bu summation of sub-scores. Score range 0-15. Lower score corresponds to milder disease. \\<7 is considered mild, 7-12 moderate. Responsiveness to ED therapy (assessed by PIS Score at End of ED Stay) is expected to be an independent risk factor for the primary outcome, therefore it is considered a Baseline Measure.", "paramType": "MEDIAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "units on a scale", "classes": [{"title": "PIS Score at ED arrival", "categories": [{"measurements": [{"groupId": "BG000", "value": "4", "spread": "2"}, {"groupId": "BG001", "value": "5", "spread": "2.85"}, {"groupId": "BG002", "value": "4", "spread": "2.53"}]}]}, {"title": "PIS Score at End of ED Stay", "categories": [{"measurements": [{"groupId": "BG000", "value": "2", "spread": "1.35"}, {"groupId": "BG001", "value": "1", "spread": "1.09"}, {"groupId": "BG002", "value": "1", "spread": "1.23"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Treatment Failure", "description": "number of patients who experience any of the following outcomes - unplanned hospital admission for asthma symptoms, unplanned ED visit for asthma symptoms, unplanned urgent care visit for asthma symptoms, unplanned primary care physician visit for asthma symptoms, or prescription of a course of steroids", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "5 days", "groups": [{"id": "OG000", "title": "Control", "description": "Patients are given one dose of oral dexamethasone 0.6 milligrams per kilogram up to 16 milligrams in the ED and a second dose of 0.6 milligrams per kilogram up to 16 milligrams to take 24 hours after ED visit\n\nDexamethasone"}, {"id": "OG001", "title": "Investigational", "description": "Patients are given one dose of oral dexamethasone 0.6 milligrams per kilogram up to 16 milligrams in the ED and placebo to be taken 24 hours after ED visit\n\nDexamethasone\n\nplacebo: to be given to the experimental group on the day after discharge from the ED in lieu of the second dose of dexamethasone"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "37"}, {"groupId": "OG001", "value": "39"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "3"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.3", "statisticalMethod": "Chi-squared", "paramType": "Odds Ratio (OR)", "paramValue": "2.32", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.54", "ciUpperLimit": "10.07"}]}, {"type": "SECONDARY", "title": "Change in Symptom Severity From Day 1 to Day 5", "description": "Severity of asthma symptoms as reported by the Patient Self Assessment Score. Patients assessed severity of asthma symptoms in 4 categories (wheezing, coughing, activity and sleep) once per day during the 5 days between study enrollment and follow-up. Score range is 0 - 12 with 0 being mildest symptoms and 12 being most severe symptoms. Reported as change in score between enrollment (day 1) and follow-up (day 5).", "populationDescription": "Participants who had complete data available for analysis", "reportingStatus": "POSTED", "paramType": "MEDIAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "score on a scale", "timeFrame": "5 days", "groups": [{"id": "OG000", "title": "Control", "description": "Patients are given one dose of oral dexamethasone 0.6 milligrams per kilogram up to 16 milligrams in the ED and a second dose of 0.6 milligrams per kilogram up to 16 milligrams to take 24 hours after ED visit\n\nDexamethasone"}, {"id": "OG001", "title": "Investigational", "description": "Patients are given one dose of oral dexamethasone 0.6 milligrams per kilogram up to 16 milligrams in the ED and placebo to be taken 24 hours after ED visit\n\nDexamethasone\n\nplacebo: to be given to the experimental group on the day after discharge from the ED in lieu of the second dose of dexamethasone"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "22"}, {"groupId": "OG001", "value": "11"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-4", "spread": "3.39"}, {"groupId": "OG001", "value": "-4", "spread": "3.29"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.95", "statisticalMethod": "t-test, 2 sided"}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "Duration of study participation - 5 days", "eventGroups": [{"id": "EG000", "title": "Control", "description": "Patients are given one dose of oral dexamethasone 0.6 milligrams per kilogram up to 16 milligrams in the ED and a second dose of 0.6 milligrams per kilogram up to 16 milligrams to take 24 hours after ED visit\n\nDexamethasone", "deathsNumAffected": 0, "deathsNumAtRisk": 46, "seriousNumAffected": 1, "seriousNumAtRisk": 46, "otherNumAffected": 1, "otherNumAtRisk": 46}, {"id": "EG001", "title": "Investigational", "description": "Patients are given one dose of oral dexamethasone 0.6 milligrams per kilogram up to 16 milligrams in the ED and placebo to be taken 24 hours after ED visit\n\nDexamethasone\n\nplacebo: to be given to the experimental group on the day after discharge from the ED in lieu of the second dose of dexamethasone", "deathsNumAffected": 1, "deathsNumAtRisk": 51, "seriousNumAffected": 1, "seriousNumAtRisk": 51, "otherNumAffected": 1, "otherNumAtRisk": 51}], "seriousEvents": [{"term": "respiratory failure", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 46}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 51}]}, {"term": "Hospitalization", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 46}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 51}]}], "otherEvents": [{"term": "vomiting", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 46}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 51}]}]}, "moreInfoModule": {"limitationsAndCaveats": {"description": "Target enrollment was not reached."}, "certainAgreement": {"piSponsorEmployee": true}, "pointOfContact": {"title": "Christopher P Kelly", "organization": "New York Presbyterian - Brooklyn Methodist Hospital", "email": "chk9064@nyp.org", "phone": "718.780.5040"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot_SAP", "hasProtocol": true, "hasSap": true, "hasIcf": false, "label": "Study Protocol and Statistical Analysis Plan", "date": "2015-02-13", "uploadDate": "2018-11-30T08:36", "filename": "Prot_SAP_000.pdf", "size": 161403}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M7796", "name": "Emergencies", "relevance": "LOW"}, {"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}, {"id": "T170", "name": "Acute Graft Versus Host Disease", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000003907", "term": "Dexamethasone"}], "ancestors": [{"id": "D000000893", "term": "Anti-Inflammatory Agents"}, {"id": "D000000932", "term": "Antiemetics"}, {"id": "D000001337", "term": "Autonomic Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000005765", "term": "Gastrointestinal Agents"}, {"id": "D000005938", "term": "Glucocorticoids"}, {"id": "D000006728", "term": "Hormones"}, {"id": "D000006730", "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"id": "D000018931", "term": "Antineoplastic Agents, Hormonal"}, {"id": "D000000970", "term": "Antineoplastic Agents"}], "browseLeaves": [{"id": "M7102", "name": "Dexamethasone", "asFound": "Health", "relevance": "HIGH"}, {"id": "M235549", "name": "Dexamethasone acetate", "relevance": "LOW"}, {"id": "M199152", "name": "BB 1101", "relevance": "LOW"}, {"id": "M4217", "name": "Anti-Inflammatory Agents", "relevance": "LOW"}, {"id": "M4251", "name": "Antiemetics", "relevance": "LOW"}, {"id": "M8881", "name": "Gastrointestinal Agents", "relevance": "LOW"}, {"id": "M9047", "name": "Glucocorticoids", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M9788", "name": "Hormone Antagonists", "relevance": "LOW"}, {"id": "M20966", "name": "Antineoplastic Agents, Hormonal", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Infl", "name": "Anti-Inflammatory Agents"}, {"abbrev": "ANeo", "name": "Antineoplastic Agents"}, {"abbrev": "AnEm", "name": "Antiemetics"}, {"abbrev": "Gast", "name": "Gastrointestinal Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}